PD-1 antibodies has shown exciting clinical value and robust therapeutic potential in clinical practice. It can significantly improve progression-free survival and overall survival. Following surgery, radiotherapy, chemotherapy, and targeted therapy, cancer treatment has now entered the age of immun...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!